Prognostic signature of ovarian cancer based on 14 tumor microenvironment-related genes

Medicine (Baltimore). 2021 Jul 16;100(28):e26574. doi: 10.1097/MD.0000000000026574.

Abstract

Background: Ovarian cancer is one of the lethal gynecological diseases in women. However, using tumor microenvironment related genes to identify prognostic signature of ovarian cancer has not been discussed in detail.

Methods: The mRNA profiles of 386 ovarian cancer patients were retrieved from The Cancer Genome Atlas. Univariate Cox regression and LASSO Cox regression analyses were performed and 14 optimized prognostic genes related to tumor microenvironment were identified.

Results: The multivariate Cox hazards regression showed risk score was an independent prognostic signature for ovarian cancer. Nomogram model could reliably predict the patients' survival. Furthermore, M1 macrophages, M2 macrophages, and follicular helper T cells, differentially expressed between the high- and low-risk groups, were found to be associated with the risk score.

Conclusion: CTL-associated antigen 4 (CTLA4) and indoleamine 2,3-Dioxygenase 1 (IDO1), which were previously shown to be important immune checkpoints, probably contribute to the immunosuppressive microenvironment aberration. This study may shed light on the prognosis of ovarian cancer.

MeSH terms

  • Age Factors
  • Aged
  • Biomarkers, Tumor
  • CTLA-4 Antigen / metabolism
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism
  • Kaplan-Meier Estimate
  • Middle Aged
  • Neoplasm Staging
  • Nomograms
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / mortality
  • Ovarian Neoplasms / pathology
  • Prognosis
  • T Follicular Helper Cells / metabolism
  • Tumor Microenvironment / physiology*
  • Tumor-Associated Macrophages / metabolism

Substances

  • Biomarkers, Tumor
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Indoleamine-Pyrrole 2,3,-Dioxygenase